Last updated on April 2015

Effect of Dexamethasone Implant in Hard Exudate Complicated With Diabetic Macular Edema


Brief description of study

A Single Arm, Single Dose Study to Evaluate the Effect of intravitreal dexamethasone implant (Ozurdex®) on hard exudates of diabetic macular edema.

Detailed Study Description

Diabetic macular edema (DME) is important vision threatening complication of diabetes mellitus. Laser photocoagulation, vitrectomy, intravitreal steroid injection and intravitreal antiVEGF (anti vascular endothelial growth factor) injection are being used as treatment of DME. Sustained releasing intravitreal dexamethasone implant has been known to be effective in reducing the central retinal thickness and gain of vision for DME. Although hard exudate at macula is important pathology of DME, impact of intravitreal dexamethasone implant on hard exudate are not studied yet. Therefore the investigators designed the descriptive study to reveal the hard exudate change in DME eyes treated with intravitreal dexamethasone implant.

Clinical Study Identifier: NCT02399657

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

In Young Chung, M.D.

Gyeongsang National University Hospital
Jinju, Korea, Republic of
  Connect »

Sang Joon Lee, M.D.

Kosin University Gospel Hospital
Busan, Korea, Republic of
  Connect »

Woo Jin Jeung, M.D.

Dong-A University hospital
Busan, Korea, Republic of
  Connect »

Ji Eun Lee, M.D.

Pusan national university hospital
Busan, Korea, Republic of
  Connect »

Joo Eun Lee, M.D.

Inje University Haeundae Paik hospital
Busan, Korea, Republic of
  Connect »

Hyun Woong Kim, M.D.

Inje University Busan Paik hospital
Busan, Korea, Republic of
  Connect »

Jae Pil Shin, M.D.

Kyungpook National University Hospital
Daegu, Korea, Republic of
  Connect »

Woo Hyok Chang, M.D.

Yeungnam University Medical Center
Daegu, Korea, Republic of
  Connect »